Haohai Biological Technology's Q1 Profit Falls 19%

MT Newswires Live
04/27

Shanghai Haohai Biological Technology (SHA:688366, HKG:6826) reported an attributable profit of 73.6 million yuan for the first quarter of 2026, down 19% from 90.3 million yuan in the year-ago period, according to a Hong Kong bourse filing on Friday.

Hong Kong-listed shares of the ophthalmic products manufacturer were up nearly 2% in late morning trading on Monday.

Earnings per share were 0.32 yuan, compared with 0.39 yuan in the prior year.

Revenue fell 7.6% year on year to 571.4 million yuan, figures showed.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10